Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Laila A. Gharzai, Ralph Jiang, David G. Wallington, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 3, pp. 402-410
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Freddie C. Hamdy, Jenny Donovan, J. Athene Lane, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 17, pp. 1547-1558
Open Access | Times Cited: 437
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
Amar U. Kishan, Yilun Sun, Holly Hartman, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 2, pp. 304-316
Closed Access | Times Cited: 126
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
Gaëtan Devos, Wout Devlies, Gert De Meerleer, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 12, pp. 739-762
Closed Access | Times Cited: 66
Automated quality assessment of large digitised histology cohorts by artificial intelligence
Maryam Haghighat, Lisa Browning, Korsuk Sirinukunwattana, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)
Ting Martin, Fang‐I Chu, Howard M. Sandler, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 487-498
Open Access | Times Cited: 40
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
Rahul Aggarwal, Glenn Heller, David W. Hillman, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 10, pp. 1114-1123
Closed Access | Times Cited: 14
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer
V. Groen, Karin Haustermans, Floris J. Pos, et al.
European Urology (2021) Vol. 82, Iss. 3, pp. 252-257
Closed Access | Times Cited: 51
An urgent call to raise the bar in oncology
John‐John B. Schnog, Michael Samson, Rijk O. B. Gans, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 11, pp. 1477-1485
Open Access | Times Cited: 50
Salvage therapy for prostate cancer after radical prostatectomy
Nicholas G. Zaorsky, Jérémie Calais, Stefano Fanti, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 11, pp. 643-668
Closed Access | Times Cited: 42
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium
Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al.
European Urology (2022) Vol. 82, Iss. 1, pp. 106-114
Open Access | Times Cited: 30
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients
Esther Wit, G.H. KleinJan, Anne‐Claire Berrens, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 9, pp. 2861-2871
Closed Access | Times Cited: 21
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate
Soumyajit Roy, Tahmineh Romero, Jeff M. Michalski, et al.
Journal of Clinical Oncology (2023)
Open Access | Times Cited: 17
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis
Paweł Rajwa, Benjamin Pradère, Giorgio Gandaglia, et al.
European Urology (2022) Vol. 82, Iss. 1, pp. 82-96
Open Access | Times Cited: 27
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy
Constantinos Zamboglou, Iosif Strouthos, Jörg Sahlmann, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 113, Iss. 5, pp. 1015-1024
Closed Access | Times Cited: 24
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
Phuoc T. Tran, Kathryn Lowe, Hua‐Ling Tsai, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 6, pp. 1307-1317
Open Access | Times Cited: 23
The State of Intermediate Clinical Endpoints as Surrogates for Overall Survival in Prostate Cancer in 2024
Marcin Miszczyk, Paweł Rajwa, Tamás Fazekas, et al.
European Urology Oncology (2024) Vol. 7, Iss. 6, pp. 1195-1198
Open Access | Times Cited: 6
Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center
Christoph Würnschimmel, Mike Wenzel, Nuowei Wang, et al.
Urologic Oncology Seminars and Original Investigations (2021) Vol. 39, Iss. 12, pp. 830.e17-830.e26
Closed Access | Times Cited: 32
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
Christopher U. Jones, Stephanie L. Pugh, Howard M. Sandler, et al.
International Journal of Radiation Oncology*Biology*Physics (2021) Vol. 112, Iss. 2, pp. 294-303
Open Access | Times Cited: 28
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer
Laila A. Gharzai, Ralph Jiang, E Jaworski, et al.
NEJM Evidence (2023) Vol. 2, Iss. 4
Closed Access | Times Cited: 13
Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials
Zhishan Zhang, Qunxiong Pan, Mingdong Lu, et al.
EClinicalMedicine (2023) Vol. 63, pp. 102156-102156
Open Access | Times Cited: 10
B2B: Prostate Cancer Summary
Gagan Prakash, Caroline M. Moore, Franck Bladou, et al.
Société Internationale d’Urologie Journal (2025) Vol. 6, Iss. 1, pp. 16-16
Open Access
Superiority of 68Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting
Min Wang, Zhiyong Quan, Keke Xin, et al.
Annals of Nuclear Medicine (2025)
Closed Access
Operationalizing intermediate clinical endpoints: A pragmatic framework for prostate cancer management trials
Xingyu Xiong, Shiyu Zhang, Jiajia Du, et al.
Cancer Treatment Reviews (2025) Vol. 136, pp. 102935-102935
Closed Access
The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection
Esther Wit, Florian van Beurden, G.H. KleinJan, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 5, pp. 1743-1753
Closed Access | Times Cited: 22
Correlation Between Periprocedural Myocardial Infarction, Mortality, and Quality of Life in Coronary Revascularization Trials: A Meta-analysis
Mario Gaudino, Antonino Di Franco, Arnaldo Dimagli, et al.
Journal of the Society for Cardiovascular Angiography & Interventions (2023) Vol. 2, Iss. 3, pp. 100591-100591
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top